The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene

被引:41
作者
Albertini, R
Clewell, H
Himmelstein, MW
Morinello, E
Olin, S [1 ]
Preston, J
Scarano, L
Smith, MT
Swenberg, J
Tice, R
Travis, C
机构
[1] ILSI, Risk Sci Inst, Washington, DC 20005 USA
[2] Univ Vermont, Burlington, VT 05401 USA
[3] ENVIRON Int, Ruston, LA 71270 USA
[4] DuPont Haskell Lab, Newark, DE 19714 USA
[5] US EPA, Hlth Effects Res Lab, Res Triangle Pk, NC 27711 USA
[6] Univ Calif Berkeley, Berkeley, CA 94720 USA
[7] Univ N Carolina, Chapel Hill, NC 27599 USA
[8] Integrated Lab Syst Inc, Res Triangle Pk, NC 27709 USA
[9] Quest Technol, Knoxville, TN 37909 USA
关键词
cancer; risk assessment; biomarkers; 1,3-butadiene; benzene; vinyl chloride; principles;
D O I
10.1016/S0273-2300(02)00019-3
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The estimation and characterization of a cancer risk is grounded in the observation of tumors in humans and/or experimental animals. Increasingly, however, other kinds of data (non-tumor data) are finding application in cancer risk assessment. Metabolism and kinetics, adduct formation, genetic damage, mode of action, and biomarkers of exposure, susceptibility, and effects are examples. While these and other parameters have been studied for many important chemicals over the past 30-40 years, their use in risk assessments is more recent, and new insights and opportunities are continuing to unfold. To provide some perspective on this field, the ILSI Risk Science Institute asked a select working group to characterize the pertinent non-tumor data available for 1,3-butadiene, benzene, and vinyl chloride and to comment on the utility of these data in characterizing cancer risks. This paper presents the findings of that working group and concludes with 15 simple principles for the use of non-tumor data in cancer risk assessment. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:105 / 132
页数:28
相关论文
共 178 条
  • [1] *AG TOX SUBST DIS, 1997, TOX PROF BENZ UPD
  • [2] AKSOY M, 1972, BRIT J IND MED, V29, P56
  • [3] Biomarkers for assessing occupational exposures to 1,3-butadiene
    Albertini, RJ
    Sram, RJ
    Vacek, PM
    Lynch, J
    Wright, M
    Nicklas, JA
    Boogaard, PJ
    Henderson, RF
    Swenberg, JA
    Tates, AD
    Ward, JB
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 135 : 429 - 453
  • [4] ALBERTINI RJ, 2003, BIOMARKER RESPONSES
  • [5] ALBERTINI RJ, 2001, CHEM-BIOL INTERACT, P135
  • [6] Common themes in the pathogenesis of acute myeloid leukemia
    Alcalay, M
    Orleth, A
    Sebastiani, C
    Meani, N
    Chiaradonna, F
    Casciari, C
    Sciurpi, MT
    Gelmetti, V
    Riganelli, D
    Minucci, S
    Fagioli, M
    Pelicci, PG
    [J]. ONCOGENE, 2001, 20 (40) : 5680 - 5694
  • [7] Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker
    Ammenheuser, MM
    Bechtold, WE
    Abdel-Rahman, SZ
    Rosenblatt, JI
    Hastings-Smith, DA
    Ward, JB
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (12) : 1249 - 1255
  • [8] A comparison of male-mediated effects in rats and mice exposed to 1,3-butadiene
    Anderson, D
    Hughes, JA
    Edwards, AJ
    Brinkworth, MH
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 397 (01) : 77 - 84
  • [9] [Anonymous], 1999, IARC Monogr Eval Carcinog Risks Hum, V71 Pt 1, P109
  • [10] [Anonymous], 2000, EPA635R00004